Watson Gets License From Teva As Part Of Settlement

Law360, New York (May 7, 2010, 6:09 PM EDT) -- Watson Pharmaceuticals Inc. said Friday that it had reached a settlement with Teva Pharmaceutical Industries Ltd. in a patent infringement dispute over the oral contraceptive Seasonale.

Under the settlement agreement, Teva subsidiary Teva Women's Health Inc. will grant Watson subsidiary Watson Laboratories Inc. a fully paid-up license to the U.S. patents covering Seasonale tablets, and Watson will continue marketing its generic equivalent product known as Quasense, according to Watson.

Morristown, N.J.-based Watson admitted that the licensed patents were valid and enforceable, but the remaining terms of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.